Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane

Journal of Cell Biology

Volumn 171, Issue 2, 2005, Pages 361-371

  Okada, Tomoyo ^a   Lopez Lago, Miguel ^a   Giancotti, Filippo G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; MERLIN; MUTANT PROTEIN; P21 ACTIVATED KINASE; PROTEIN; PROTEIN NF 2; RAC PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CONTACT INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

CELL ADHESION; CELL MEMBRANE; CELL PROLIFERATION; CONTACT INHIBITION; ENDOTHELIAL CELLS; HUMANS; NEUROFIBROMIN 2; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RAC GTP-BINDING PROTEINS; RNA, SMALL INTERFERING;

EID: 27544514090     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200503165     Document Type: Article

References (45)

1. Abassi, Y.A., and K. Vuori. 2002. Tyrosine 221 in Crk regulates adhesiondependent membrane localization of Crk and Rac and activation of Rac signaling. EMBO J. 21:4571-4582.
2. Balasenthil, S., A.A. Sahin, C.J. Barnes, R.A. Wang, R.G. Pestell, R.K. Vadlamudi, and R. Kumar. 2004. Pak-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J. Biol. Chem. 279:1422-1428.
3. Bekri, S., J. Adelaide, S. Merscher, J. Grosgeorge, F. Caroli-Bosc, D. Perucca-Lostanlen, P.M. Kelley, M.J. Pebusque, C. Theillet, D. Birnbaum, and P. Gaudray. 1997. Detailed map of a region commonly amplified at 11q13->q14 in human breast carcinoma. Cytogenet. Cell Genet. 79:125-131.
4. Bokoch, G.M. 2003. Biology of the p21-activated kinases. Annu. Rev. Biochem. 72:743-781.
5. Braga, V.M. 2002. Cell-cell adhesion and signalling. Curr. Opin. Cell Biol. 14:546-556.
6. Bretscher, A., K. Edwards, and R.G. Fehon. 2002. ERM proteins and Merlin: integrators at the cell cortex. Nat. Rev. Mol. Cell Biol. 3:586-599.
7. Callow, M.G., F. Clairvoyant, S. Zhu, B. Schryver, D.B. Whyte, J.R. Bischoff, B. Jallal, and T. Smeal. 2002. Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J. Biol. Chem. 277:550-558.
8. Carmeliet, P., M.G. Lampugnani, L. Moons, F. Breviario, V. Compernolle, F. Bono, G. Balconi, R. Spagnuolo, B. Oostuyse, M. Dewerchin, et al. 1999. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell. 98:147-157.
9. Carter, J.H., L.E. Douglass, J.A. Deddens, B.M. Colligan, T.R. Bhatt, J.O. Pemberton, S. Konicek, J. Hom, M. Marshall, and J.R. Graff. 2004. Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin. Cancer Res. 10:3448-3456.
10. del Pozo, M.A., L.S. Price, N.B. Alderson, X.D. Ren, and M.A. Schwartz. 2000. Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK. EMBO J. 19:2008-2014.
11. del Pozo, M.A., W.B. Kiosses, N.B. Alderson, N. Meller, K.M. Hahn, and M.A. Schwartz. 2002. Integrins regulate GTP-Rac localized effector interactions through dissociation of Rho-GDI. Nat. Cell Biol. 4:232-239.
12. del Pozo, M.A., N.B. Alderson, W.B. Kiosses, H.H. Chiang, R.G. Anderson, and M.A. Schwartz. 2004. Integrins regulate Rac targeting by internalization of membrane domains. Science. 303:839-842.
13. DerMardirossian, C., A. Schnelzer, and G.M. Bokoch. 2004. Phosphorylation of RhoGDI by Pak1 mediates dissociation of Rac GTPase. Mol. Cell. 15:117-127.
14. Dulbecco, R., and M.G. Stoker. 1970. Conditions determining initiation of DNA synthesis in 3T3 cells. Proc. Natl. Acad. Sci. USA. 66:204-210.
15. Ehrlich, J.S., M.D. Hansen, and W.J. Nelson. 2002. Spatio-temporal regulation of Rac1 localization and lamellipodia dynamics during epithelial cell-cell adhesion. Dev. Cell. 3:259-270.
16. Etienne-Manneville, S., and A. Hall. 2002. Rho GTPases in cell biology. Nature. 420:629-635.
17. Fernandez-Valle, C., Y. Tang, J. Ricard, A. Rodenas-Ruano, A. Taylor, E. Hackler, J. Biggerstaff, and J. Iacovelli. 2002. Paxillin binds Schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat. Genet. 31:354-362.
18. Giovannini, M., E. Robanus-Maandag, M. van der Valk, M. Niwa-Kawakita, V. Abramowski, L. Goutebroze, J.M. Woodruff, A. Berns, and G. Thomas. 2000. Conditional biallelic NF2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev. 14:1617-1630.
19. Gottardi, C.J., and B.M. Gumbiner. 2001. Adhesion signaling: how -catenin interacts with its partners. Curr. Biol. 11:R792-R794.
20. Hanahan, D., and R.A. Weinberg. 2000. The hallmarks of cancer. Cell. 100:57-70.
21. Johnson, K.C., J.L. Kissil, J.L. Fry, and T. Jacks. 2002. Cellular transformation by a FERM domain mutant of the NF2 tumor suppressor gene. Oncogene. 21:5990-5997.
22. King, A.J., H. Sun, B. Diaz, D. Barnard, W. Miao, S. Bagrodia, and M.S. Marshall. 1998. The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. Nature. 396:180-183.
23. Kissil, J.L., K.C. Johnson, M.S. Eckman, and T. Jacks. 2002. Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization. J. Biol. Chem. 277:10394-10399.
24. Kissil, J.L., E.W. Wilker, K.C. Johnson, M.S. Eckman, M.B. Yaffe, and T. Jacks. 2003. Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1. Mol. Cell. 12:841-849.
25. LaJeunesse, D.R., B.M. McCartney, and R.G. Fehon. 1998. Structural analysis of Drosophila Merlin reveals functional domains important for growth control and subcellular localization. J. Cell Biol. 141:1589-1599.
26. Lallemand, D., M. Curto, I. Saotome, M. Giovannini, and A.I. McClatchey. 2003. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev. 17:1090-1100.
27. Lampugnani, M., A. Zanetti, M. Corada, T. Takahashi, G. Balconi, F. Breviario, F. Orsenigo, A. Cattelino, R. Kemler, T.O. Daniel, and E. Dejana. 2003. Contact inhibition of VEGF-induced proliferation requires vesicular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148. J. Cell Biol. 161:793-804.
28. Lim, D.J., A.E. Rubenstein, D.G. Evans, T. Jacks, B.G. Seizinger, M.E. Baser, D. Beebe, D.E. Brackmann, E.A. Chiocca, R.G. Fehon, et al. 2000. Advances in neurofibromatosis 2 (NF2): a workshop report. J. Neurogenet. 14:63-106.
29. Maeda, M., T. Matsui, M. Imamura, and S. Tsukita. 1999. Expression level, subcellular distribution and Rho-GDI binding affinity of Merlin in comparison with Ezrin/Radixin/Moesin proteins. Oncogene. 18:4788-4797.
30. McClatchey, A.I., I. Saotome, K. Mercer, D. Crowley, J.F. Gusella, R.T. Bronson, and T. Jacks. 1998. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev. 12:1121-1133.
31. McCrea, P.D., W.M. Brieher, and B.M. Gumbiner. 1993. Induction of a secondary body axis in Xenopus by antibodies to β-catenin. J. Cell Biol. 123:477-484.
32. Mettouchi, A., S. Klein, W. Guo, M. Lopez-Lago, E. Lemichez, J.K. Westwick, and F.G. Giancotti. 2001. Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle. Mol. Cell. 8:115-127.
33. Morrison, H., L.S. Sherman, J. Legg, F. Banine, C. Isacke, C.A. Haipek, D.H. Gutmann, H. Ponta, and P. Herrlich. 2001. The NF2 tumor suppressor gene product, Merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev. 15:968-980.
34. Qian, X., T. Karpova, A.M. Sheppard, J. McNally, and D.R. Lowy. 2004. E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J. 23:1739-1784.
35. Rahimi, N., and A. Kazlauskas. 1999. A role for cadherin-5 in regulation of VEGF-R 2 activity in endothelial cells. Mol. Biol. Cell. 10:3401-3407.
36. Sahai, E., and C.J. Marshall. 2002. RHO-GTPases and cancer. Nat. Rev. Cancer. 2:133-142.
37. Schram, L.P., G. Schwerdtfeger, F. Burkhalter, A. Raggi, D. Schmidt, T. Ruffalo, W. King, K. Wilber, M.J. Mihatsch, and H. Moch. 2003. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am. J. Pathol. 163:985-992.
38. Shaw, R.J., J.G. Paez, M. Curto, A. Yaktine, W.M. Pruitt, I. Saotome, J.P. O'Bryan, V. Gupta, N. Ratner, C.J. Der, et al. 2001. The NF2 tumor suppressor, Merlin, functions in Rac-dependent signaling. Dev. Cell. 1:63-72.
39. Speck, O., S.C. Hughes, N.K. Noren, R.M. Kulikauskas, and R.G. Fehon. 2003. Moesin functions antagonistically to the Rho pathway to maintain epithelial integrity. Nature. 421:83-87.
40. Stickney, J.T., W.C. Bacon, M. Rojas, N. Ratner, and W. Ip. 2004. Activation of the tumor suppressor merlin modulates its interaction with lipid rafts. Cancer Res. 64:2717-2724.
41. Surace, E.I., C.A. Haipek, and D.H. Gutmann. 2004. Effect of Merlin phosphorylation on neurofibromatosis 2 (NF2) gene function. Oncogene. 23:580-587.
42. Turner, C.E. 2000. Paxillin and focal adhesion signalling. Nat. Cell Biol. 2:E231-E236.
43. Vermeer, P.D., L.A. Einwalter, T.O. Moninger, T. Rokhlina, J.A. Kern, J. Zabner, and M.J. Welsh. 2003. Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature. 422:322-326.
44. Xiao, G.H., A. Beeser, J. Chernoff, and J.R. Testa. 2002. p21-activated kinase links Rac/Cdc42 signaling to Merlin. J. Biol. Chem. 277:883-886.
45. Yablonski, D., L.P. Kane, D. Qian, and A. Weiss. 1998. A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK. EMBO J. 17:5647-5657.